FDA has granted accelerated approval of Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor CAR T-cell therapy for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma who have received at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 (BCL-2) inhibitor.
FDA has approved Tevimbra (tislelizumab-jsgr) as monotherapy for the treatment of adult patients with unresectable or metastatic esophageal squamous cell carcinoma after prior systemic chemotherapy that did not include a PD-(L)1 inhibitor.
Source: White HouseIn a fiery State of the Union speech designed to showcase his performance as a veteran politician, President Joe Biden leaned into his accomplishments in health care.
NCI and Cancer Research UK awarded $125 million in total funding through the Cancer Grand Challenges program, supporting research on cancer inequities, early-onset cancers, solid tumors in children, and T-cell receptors. The $125 million investment marks the Cancer Grand Challenges program’s largest funding round to date.
Diane M. Simeone will become director of Moores Cancer Center at UC San Diego Health effective April 1.
Kenneth C. Griffin, founder and CEO of Citadel and founder of Griffin Catalyst, gifted $50 million to Sylvester Comprehensive Cancer Center to help fund a 12-story, 244,000-square-foot cancer research building.
The American Association for Cancer Research presented its 2023 Annual Impact Report.
Rutgers Cancer Institute of New Jersey, together with RWJBarnabas Health, the state’s only NCI-designated Comprehensive Cancer Center, was redesignated by NCI.
Denene Prophet-Williams was named vice president and chief nursing officer at Fred Hutchinson Cancer Center. Prophet-Williams is an accomplished health care executive with a 30-year nursing career, characterized by her leadership and strategic vision in academic, Magnet-designated, and community hospitals. She will begin the role April 1.
Michael EggerChristopher ManzSerena PhillipsMichael Egger, Christopher Manz, and Serena Phillips received the 2023 Real-World Data Impact Award from the American Cancer Society and Flatiron Health.
